+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Labetalol in the treatment of elderly patients with mild essential hypertension



Labetalol in the treatment of elderly patients with mild essential hypertension



Journal of the American Osteopathic Association 88(3): 359-364



Fifty-two elderly hypertensive patients with standing diastolic (90-110 mm Hg) or systolic (160-240 mm Hg) blood pressure elevations were assigned randomly to receive labetalol or placebo in a double-blind study. Baseline standing blood pressure in the two groups were similar. The goal of treatment was to reduce standing pressure to < 150/< 90 mm Hg (or, for systolic pressure, a decrease of at least 10%). If blood pressure was uncontrolled after labetalol or placebo use for four weeks, hydrochlorothiazide (HCTZ) was added. During the titration phase, goal blood pressure was achieved by all 25 patients receiving labetalol, and 20 of these 25 required < 200 mg twice a day. No patient receiving labetolol required addition of HCTZ. By contrast, HCTZ was required by 12 of 25 (48%) placebo patients, eight of whom were controlled by the end of titration. By the end of the four-week maintenance phase, 18 of 25 (72%) patients receiving labetalol and 10 of 21 (48%) patients receiving placebo or placebo and HCTZ had blood pressures with the target range (P < .05). No patient withdrew because of drug-related adverse events. Labetolol in low dosages appears to be an effective and well-tolerated antihypertensive monotherapy in elderly patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005787155

Download citation: RISBibTeXText

PMID: 3360638


Related references

Treatment of essential hypertension in the elderly with labetalol. Japanese Archives of Internal Medicine 34(12): 459-466, 1987

Evaluation of labetalol in elderly patients with essential hypertension. Journal of Clinical Pharmacology 31(6): 556-560, 1991

Chlorthalidone at low doses in the treatment of mild to moderate essential hypertension in elderly patients. Arquivos Brasileiros de Cardiologia 50(6): 427-430, 1988

Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension. European Journal of Clinical Pharmacology 35(1): 9-15, 1988

Labetalol in the treatment of hypertension in elderly and younger patients. Journal of Clinical Pharmacology 27(11): 902-906, 1987

Carvedilol vs labetalol in treating mild to moderate essential hypertension. Zhongguo Xinyao yu Linchuang Zazhi 19(3): 181-184, 2000

Effects of prazosin and labetalol on blood pressure control and blood lipid levels in patients with mild-to-moderate essential hypertension. American Journal of Medicine 86(1b): 41-44, 1989

Effect of labetalol on exercise tolerance and double product in mild to moderate essential hypertension. American Journal of Medicine 78(6 PART 1): 937-941, 1985

Chronic treatment of patients with essential hypertension and ischemic heart disease with labetalol a clinical ergometric and hemodynamic evaluation. Condorelli, M And A Zanchetti (Ed ) Hypertension: Recent Advances And Research; Proceedings Of The International Symposium, Sorrento, Italy, Oct 18-20, 1980 Xi+152p Cortina International: Verona, Italy (Dist in The Usa By Raven Press: New York, N Y ) Illus P85-96, 1982

A study on the efficacy and safety of losartan in elderly patients with mild to moderate essential hypertension. International Urology and Nephrology 32(4): 519-523, 2001

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension. Blood Pressure. Supplement 1: 3-11, 2011

The relationship between the autonomic nervous function and early renal dysfunction in elderly patients with mild-to-moderate essential hypertension. Clinical and Experimental Hypertension 40(2): 136-140, 2017

Treatment of hypertension in the elderly with labetalol. PharmacoTherapy 9(5): 295-302, 1989

Step II treatment with labetalol for essential hypertension. American Journal of Medicine 75(4a): 81-86, 1983

Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study. American Journal of Medicine 75(4a): 47-53, 1983